| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Scienta Lab AI-powered Precision Immunology Scienta Lab is a deeptech company developing a unique and proprietary artificial intelligence technology to transform the drug discovery and development process in immunology and inflammation. Artificial Intelligence, Clinical Trials, and Immunology Type: | 17 | 4 | 15 | 10 |
 |  NBread conçoit et industrialise vos innovations... NBread-Process is an breakthrough innovative technology and a pioneering product, protected by a patent and carried by a patent and carried by a team that imagines and develops solid food foams from any raw material. Type: | 1 | 1 | 0 | 3 |
 |  Temisis Therapeutics Biotech developing novel first-in-class small-molecules to treat immuno-inflammatory diseases with high unmet needs “Temisis Therapeutics ("Temisis") is a pre-clinical stage biotechnology company developing innovative drugs derived from natural sources for the treatment of auto-immune and chronic inflammatory diseases, with an initial focus on psoriasis. Temisis most advanced compound, TEM-1657, a first-in-class and orally bioavailable small molecule, has demonstrated highly promising preclinical efficacy and safety profile in animal model of psoriasis, superior to Apremilast (Otezla TM), a Standard of Care (SOC) for patients with mild to moderate plaque psoriasis. In addition, TEM-1657 exhibited strong protective effect against Ulcerative Colitis (UC) in … Type: | 4 | 2 | 3 | 2 |
 | ReACT Therapeutics [Automatic translation follows] Breaking resistance barrier in oncology. ReACT Therapeutics is a French biotech company that works to restore the effectiveness of cancer treatments and improve the quality of care provided to patients. Created in January 2023 in Grenoble, ReACT Therapeutics aims to develop a new class of molecules capable of blocking multiresistance phenomena responsible for therapeutic failures. ➡️ Our mission: Working for and with patients to restore the effectiveness of their cancer treatments and improve the quality of their care. ➡️ Our goal: Developing a new class of molecules capable of blocking multiresistance phenomena in oncology. The result of … Type: | 24 | 8 | 20 | 2 |
 | myDiabby Healthcare [Automatic translation follows] The telemedicine platform for monitoring diabetes. myDiabby has been the leading medical telemonitoring platform for diabetes in France for 9 years. Specializing in monitoring type 1, type 2 and gestational diabetes, the first patients have benefited from reimbursement of the platform by health insurance since July 2023. Used by the majority of university hospitals, hospitals, clinics and city doctors connected in a vast French-speaking network, myDiabby is the most widespread telemedicine platform dedicated to diabetes management in France. Several thousand patients are registered each month and benefit from telemedical monitoring throughout the country. telemedicine, diabetes, Gestational Diabetes, … Type: | 9 | 1 | 8 | 24 |
 | Inpart An online platform for scientific partnering helping take discoveries from bench to bedside. Inpart is the leading platform for scientific partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia. In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry. The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations. … | 29 | 3 | 23 | 200 |
 |  Nosty Making Pharma democratic. Nosty is a decentralized platform where stakeholders in drug development work together to bring new therapeutics to patients faster and more efficiently than ever. The platform enables leading researchers and labs to raise fund among patients and the general public by turning IP and its development into a liquid and easily investable asset. The project is led by a team of serial entrepreneurs and professionals from the pharmaceutical industry, based in US and Europe. Type: | 2 | 2 | 0 | 1 |
 | SeqOne From Genome to Personalized Medicine Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases. SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies. By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all. The company has won numerous awards, … Type: | 14 | 6 | 8 | 84 |
 | VG2D Pharma A better health accessible to all patients Serious diseases and their impact on patients is what fuels our innovative approach to solving patients' unmet needs. We are leading a new way to treating cystic fibrosis and other disease in need of new solutions. Cystic Fibrosis, Bone Diseases, and Inflammatory Diseases Type: | 7 | 2 | 2 | 1 |
 | Eurofins CALIXAR Native and functional membrane therapeutic targets for improving Drug and Vaccine Discovery To contact us : contact@calixar.com CALIXAR, is a biotech company specialized in the functional and native isolation of complex membrane therapeutic targets and antigens. We develop and implement chemistry and biochemistry tools to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity. Our approach represents the opportunity for pharmaceutical companies to start and work with high quality targets or antigens before developing antibodies, formulating vaccines and/or discovering a primary lead through Structure Based Drug Design or High … Type: | 13 | 7 | 7 | 17 |
 | AnyGenes® Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by … Type: | 0 | 0 | 0 | 6 |
 | Nova In Silico Nova has built jinkō, a unique in silico clinical trial simulation platform to de-risk and accelerate clinical trials Nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations. Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials. Predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed … Type: | 18 | 7 | 11 | 58 |
 | KADALYS La première marque éco consciente et bio experte de la science du bananier KADALYS is the first organic and eco-conscious skincare brand that upcycles banana agri-waste into patented and clinically proven bio-actives that rejuvenate skin. Inspired by French Caribbean traditional medicine, and backed by 10 years of research, KADALYS products are certified organic, vegan, and cruelty-free while adhering to ethical, sustainable, and fair-trade practices. All planters are also shareholders. The brand's ingredients are sourced and manufactured in an ethical and eco-friendly way. KADALYS is Black and female founded. --------- Première marque de cosmétologie naturelle aux actifs de Bananier Soins anti-âge … Type: | 16 | 9 | 5 | 14 |
 | 4P-Pharma Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, … Type: | 30 | 8 | 25 | 27 |
 | ELSALYS BIOTECH Innovative medicines to address haemato-oncology related life-threatening and rare diseases ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases. Following strategic acquisitions and targeted developments, ElsaLys is establishing an immunotherapeutic portfolio focused on niche specialty pharmaceuticals to answer unmet medical needs. Our commitment is to offer essential drugs meeting Public Health needs. Founded in 2013, ElsaLys Biotech is located in the heart of the European cluster Lyon Biopole, in Lyon, France. Anticorps thérapeutiques, Anticorps monoclonaux, Therapeutic antibodies, Monoclonal antibodies, ophtalmologie, immune microenvironment, vascular … Type: | 7 | 3 | 1 | 1 |
 | LinKinVax LinKinVax aims at creating a universal, safe, enduring, vaccines platform against multiple pathogens. We are a clinical stage Biotech Spin-off of the Vaccine Research Institute in France with a unique "DC targeting" platform covering infectious desaeses and oncology. Type: | 11 | 0 | 11 | 5 |
 | inalve Feeding the world sustainably, without compromise on Productivity, Environment, Naturalness & Health. In algae veritas Building a sustainable future together. Microalgae are able to propose solutions to many challenges of the positive economy. We cultivate them for various applications and animal nutrition in particular. contact@inalve.com Feed, Protéines végétales, Agro-industrie, sustainability , innovation, aquaculture, nutraceutic, biotechnology, microalgae, ingredients, nutrition, and health Type: | 36 | 21 | 23 | 23 |
 | NeoVentures Biotechnology Europe Aptamarker Platform | High-Plex Proteomics | Biomarker Discovery | Advanced DNA Aptamer Library & Machine Learning At NeoVentures Biotechnology Europe we are committed to revolutionizing the biopharmaceutical field through a cutting-edge biomarker discovery platform, propelling the industry towards personalized medicine with rapid, cost-effective, and automated processes for biomarker discovery and validation. Our Aptamarker platform leverages a library of 16.8 million DNA aptamers to analyze epitope profiles in biofluids, liquid biopsy or tissue, facilitating the precise measurement of surrogate biomarkers and expediting the creation of predictive In Vitro Diagnostic (IVD) tests tailored to distinct pathophysiological conditions. With our advanced DNA aptamer … Type: | 1 | 1 | 0 | 4 |
 | Tafalgie Therapeutics [Automatic translation follows] Research contributing to health and well-being: innovative polypeptides for the prevention & treatment of pain Tafalgie Therapeutics is a spin-off company of CNRS and AMU engaged in biopharmaceutical research and committed to the development of a new scientific approach for next-generation treatments based on a breakthrough innovation: a mechanism of action derived from an endogenous secreted protein capable of modulating pain signals. Tafalgie Therapeutics aims to become the leading player in the field of pain, by designing and proposing new pharmaceutical active ingredients based on the development of polypeptides derived from TAFA4. At Tafalgie Therapeutics, we aim … Type: | 33 | 10 | 9 | 15 |
 | Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … Tags: FrenchTech2030 Type: | 18 | 5 | 13 | 51 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidate. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Three Pillars; Safety, Efficacy, Manufacturing are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan to execution More, we have implemented a human and customer centric organization to … Type: | 2 | 1 | 2 | 3 |
 | BioSerenity Connected & integrated neurosciences. Brain monitoring & remote diagnostic BioSerenity develops connected medical solutions to help diagnose and monitor patients with chronic diseases in neurology, sleep disorders and cardiology. We use physiological sensors, an IoT platform, apps and A.I. to detect digital biomarkers. We work with more than 200 hospitals in Europe and in the USA and help diagnose over a hundred thousand patients per year. Our headquarter is in Paris, France. The US main office is located in greater Boston area (Danvers) in Massachusetts. Medical Devices, e-Health, Neurology, Smart Clothing, Mobile Diagnostics, Sleep, Research, EEG, Polysomnography, Sleep diagnostic, and … Type: | 51 | 28 | 23 | 268 |
 | Meddenovo Drug Design Meddenovo offers a unique blend of AI technologies and molecular modeling to design cyclic peptide therapeutics. **About Meddenovo** Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides. Our innovative approach leverages a unique blend of AI technologies and molecular modeling to significantly enhance the efficiency and success rates of drug development processes. **Cyclic Peptides: The Future of Drug Discovery** Cyclic peptides represent a groundbreaking class of compounds in pharmaceutical research. These molecules combine the best attributes of small molecules and large biologics, offering exceptional binding affinities, stability, and specificity. At … Type: | 3 | 3 | 0 | 4 |
 | NissActive SAS [Automatic translation follows] From the exploitation of natural substances of Mediterranean origin to the development of innovative cosmetic active ingredients Cosmetics is a clever mix of science, research and creativity. Three key words for Nissactive, a nascent company with tenfold ambitions, specializing in the development of natural active ingredients in order to promote and enhance biodiversity. A true source of inspiration, nature is an exploitable source of wealth, making it possible to provide customers and partners with innovative cosmetic ingredients. In order to enhance local wealth, various studies are carried out using Mediterranean plants as well as agricultural by-products through … Type: | 5 | 2 | 1 | 2 |
 | Oncofactory 🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic … Type: | 5 | 1 | 4 | 8 |
 | TargEDys From Probiotics to PreciBiomics TargEDys is a French commercial-stage biotech company specialized in the development of precision probiotics, or PreciBiomic solutions. Our mission is to detect, transpose and make available microbiome-based innovations to answer global public health challenges. How? By translating microbiome fundamental research from prestigious French institutes such as the Inserm and IGFL to applied research in probiotics, understanding the molecular mechanism of action of our strains, and developing industrial processes and IP to propose turnkey science-backed probiotics. Our vision is to bring the microbiome to the heart of healthcare and harvest its immense potential to improve the quality … Type: | 6 | 1 | 4 | 8 |
 | Epsidy Empowering clinical science Born from an electric impulse, with smart connectivity and mindful technology, we empower clinical scientists in the fight against cardiovascular diseases. Yet, the best research and diagnostic tool, Magnetic Resonance Imaging (MRI) is used too rarely, and too often as a last resort when other techniques fail. Epsidy is addressing technological and practical issues with cardiac MRI. Epsidy is a start-up co-founded by engineers and PhDs, with a solid scientific culture and decades of combined experience. Epsidy focuses on the development of MRI-compatible instrumentation for better diagnosis and more effective therapy. Epsidy core values are ownership, trust, … Type: | 5 | 2 | 3 | 5 |
 | VETBIOLIX [Automatic translation follows] Vetbiolix develops innovative products for the treatment and prevention of chronic diseases affecting dogs and cats. Type: | 3 | 3 | 0 | 7 |
 | ALPIONER Therapeutics Building a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens. Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR). Type: | 18 | 4 | 1 | 3 |
 | Agrauxine by Lesaffre Agrauxine by Lesaffre is a leading company in the field of biocontrol and biostimulant solutions based on micro-organisms (yeast, yeast derivates, fungi, bacteria). | 9 | 1 | 6 | 86 |
 | Alkion BioInnovations Disruptive solutions to produce high-value plant-based ingredients Alkion BioInnovations is a pionnier & leader in plant tissue propagation and bioengineering technologies. We have developed and patented a bioproduction platform to obtain high value ingredients (APIs, complex extracts and recombinant proteins) from plant biomass for pharmaceutical & agri-food markets on global and impactful projects. Through a carbon-neutral approach and using a minimum of resources in optimised bioreactors, our method of production is sustainable, ultra-scalable and cost-efficient. With our European partners, we develop AI robots to build the world's first industrial in-vitro bioproduction platform, that aims to be flexible and versatile. Our … Type: | 10 | 2 | 9 | 14 |
 | Atoxigen ATOXIGEN is your partner in early R&D. We offer a variety of standardized or customized assays based on the latest innovations in the fields of cellular biology, molecular biology and genomics. Innovative predictive efficacy assays on reconstructed epidermis or primary cell lines from human explants (proteasome, autophagy, detoxification, anti-ageing...); in vitro genotoxicity testing (micronucleus and chromosome aberration tests); endocrine disruptor screening; customized services. Biotechnologies, Testing & Research, Evaluation toxicologique, and Assurance qualité Type: | 2 | 0 | 2 | 3 |
 | Continuum Plus Santé [Automatic translation follows] Reinventing the monitoring of patients under anticancer drugs #AKOadom, Continuum+ Connect Telemonitoring Platform Closer to patients. cancer, health, digital, E-health, Home support, and telemonitoring Type: | 39 | 8 | 34 | 19 |
 | Apmonia Therapeutics Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1). Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1. immunologie and oncologie Type: | 28 | 12 | 20 | 18 |
 | GAIAGO [Automatic translation follows] We believe that Man is alive when the Earth is alive. We revitalize soils by restoring and strengthening the mineral and biological balance of soils. We act on the natural fertility of soils and plant nutrition for triple agronomic, economic and ecological performance. We develop, manufacture and market soil revitalization products that naturally activate their functionalities while limiting the impact of chemistry on crops. AgTech, Biotechnology, Agronomy, Soil, Biotechnology, Biostimulants, Agriculture, and Carbon Tags: FrenchTech2030 Type: | 33 | 11 | 23 | 57 |
 | ImCheck Therapeutics Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune … Tags: FrenchTech120 FrenchTech2030 Type: | 32 | 15 | 22 | 56 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 15 | 5 | 11 | 68 |
 | CleveXel Pharma Created in 2013, CleveXel Pharma is a pharmaceutical company with an innovative business model based on maximizing the marketing potential of disruptive molecules in exchange for a stake in the partner's equity or for the gradual purchase of a license. LIFE SCIENCES, PHARMACEUTICAL DEVELOPMENT, CLINICAL RESEARCH, and QUALITY / COMPLIANCE | 2 | 2 | 0 | 15 |
 | Alzohis Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat Type: | 3 | 2 | 1 | 2 |
 | StemInov Births can save lives StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology Type: | 15 | 10 | 3 | 4 |
 | Gnosis by Lesaffre Using what's alive so that we can thrive We are experts in biotransformation processes like fermentation and we cultivate actives ingredients, probiotics, nutritional and functional yeasts that benefit human health and wellbeing. We collaborate with pharmaceutical and nutraceutical brands and industries, including dietary supplements and functional foods&beverages, to develop game-changing products. We harness the power of microorganisms to produce bioactive ingredients, as Vitamin K2, SAMe, Active Folate, S.boulardii and more over to improve human health. We draw on our focused research and development capabilities, rigorous quality and regulatory standards, and extensive clinical validation procedures so that we can develop effective … Type: | 1 | 1 | 0 | 272 |
 | MedDay Pharma | 3 | 3 | 0 | 35 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 1 | 1 | 0 | 15 |
 | Poietis Make tissues real Poietis (gr. Ποίησις: to make). "The one who makes things real." Poietis is a health-tech company specialized in the development of solutions for manufacturing human tissues by 4D Bioprinting. Poietis commercializes its Next Generation Bioprinting (NGB) systems for Cell Therapy & Research Centers and also develops advanced therapies with leading clinicians. 4D Bioprinting, Tissue engineering, Laser, bioprinting, skin, and cell therapy Type: | 31 | 21 | 7 | 23 |
 | Regulaxis SAS Regenerative Medicine - Growth Disregulation - Oncology REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its … Type: | 0 | 0 | 0 | 3 |
 | X'PROCHEM We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences Type: | 1 | 0 | 1 | 13 |
 | Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI) Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents … Type: | 3 | 2 | 1 | 41 |
 | Genvade Therapeutics Dedicated to developing treatments for rare diseases originated from nonsense mutations Genvade aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases. small molecules, drug discovery and development, rare diseases, nonsense mutation corrector, cystic fibrosis, genetic diseases, oncology, readthrough, and Duchenne Type: | 2 | 2 | 0 | N/A |
 | Generare Natural molecule discovery, industrialized Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution. This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation. genomics, synbio, and microbiology Type: | 7 | 3 | 4 | 13 |
 | Igyxos Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal Type: | 2 | 1 | 2 | 11 |
 | Preclinical imaging platform - Centre Georges François Leclerc Ensemble, dépassons le cancer The preclinical imaging platform is located in the heart of the national anticancer center Georges François Leclerc in Dijon. This center already had a great experience of clinical research (phase 1/2). The preclinical imaging platform scientific team (composed of a radiopharmacist, a pharmaco-physiologist, and a radiophysician) works in close relationships with the clinics (Oncologists, nuclear medicine MDs), offering thus a full-range translational expertise preclinical to clinical. The preclinical imaging platform enables a full approach of pharmaco-imaging, from chemistry to in vivo imaging, in a totally dedicated environment. The preclinical imaging platform offers customized services including radiolabeling, … Type: | 17 | 7 | 12 | 406 |
 | DÔMES PHARMA Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health Type: | 21 | 9 | 14 | 131 |
 | THERAVECTYS Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective … Type: | 2 | 2 | 0 | 19 |
 | KEOSYS Medical Imaging Better Imaging for your Clinical Trials "We collect, centralize and analyse imaging data for your clinical trial, using our ISO certified quality system" Founded in 2001, Keosys has established itself as a leading full-service Imaging CRO focused on bringing high quality images and services to its customers. With over 20 years’ experience in medical imaging, Keosys helps pharmaceutical and biotechnology companies bring new drugs to market by leveraging imaging data in clinical trials. In addition to its leading proprietary cloud-based platform to centralize and analyze imaging data Keosys offers project management services and scientific expertise that allow sponsors to focus … Type: | 3 | 2 | 2 | 39 |
 | Coriolis Pharma Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large … Type: | 0 | 0 | 0 | 170 |
 | TECH4HEALTH [Automatic translation follows] Supporting health technologies throughout their maturation cycle. A network of expertise composed of responsive platforms, which answer the "Why, When and How to carry out preclinical and clinical studies". The network aims to encourage initiatives and facilitate the realization of multidisciplinary and collaborative translational research projects in the field of the evaluation of medical devices, e-Health and biomaterials. It is a national network bringing together academic expertise in regulation and evaluation for the development of medical devices, e-Health and biomaterials throughout their life cycle. These axes may be expanded according to the needs, strategic issues and resources … Type: | 1 | 1 | 0 | 3 |
 | Cancéropôle Est [Automatic translation follows] Our goal, to facilitate and promote innovative cancer research. 3 levers to develop, promote & boost cancer research in the Grand Est and Bourgogne-Franche-Comté regions: - Structure, coordinate and strengthen cancer research in alliance with institutions involved in the field of fundamental, translational and clinical research. - Bring together academic, national and international players in the fight against cancer with a dual objective: the rapid transfer of discoveries to patients and the economic valorization of research. - Lead a multidisciplinary network that brings together researchers (epidemiologists, biologists, physicists, chemists, computer scientists, mathematicians, roboticists, etc.), health professionals, professionals … Type: | 21 | 4 | 2 | 9 |
 | CR2TI UMR 1064 Nantes The Center for Research in Transplantation and Immunology (CRTI) is a multidisciplinary academic research unit (UMR 1064) affiliated to INSERM and Nantes University and located at Nantes University Hospital (CHU Nantes). We develop disease-oriented basic and translational research and training programs aiming primarily at: 1. Understanding the mechanisms by which the immune system promotes or control diseases or lesions in transplantation, autoimmune, inflammatory and infectious diseases; 2. Understanding the biology of stem cell, tissue and organism development; 3. Translating these advances from the laboratory to the clinic by bringing new diagnostic and immunotherapeutic developments as well as alternative strategies for … Type: | 6 | 3 | 0 | 66 |
 | Miyoshi Europe TREATING YOU RIGHT We are the first company that created and launched silicone treated cosmetic pigments to the market, which led to the development of the epoch-making two-way cake powders which can be applied to the face by either a wet or dry sponge. From then, we continuously developed, with our original know-how and technology, various surface treatment processes, such as Amino Acid treatment, Lecithin treatment, and Ester Treatment. The combination of the said technologies and high-quality fillers (sericite, mica, talc, etc.), which are essential for the cosmetic formulation, or functional powders (ultrafine powders, silica beads, pearl, etc.) enabled us … | 2 | 1 | 0 | 58 |
 | MEDIPATH FRANCE [Automatic translation follows] DIAGNOSIS AND LOCAL EXPERTISE IN CANCER A leader in France, Medipath is a national benchmark player in the screening and diagnosis of pathologies, particularly in cancerology. With more than 25 years of expertise, Medipath pursues its public health mission by maintaining close proximity with its clinicians. A liberal company, governed by the pathologists who make it up, our desire remains unchanged: to maintain a high level of expertise and quality and to commit ourselves daily to the fight against cancer by offering top-notch services. MEDIPATH has more than 120 doctors, 12 referring pathologists in the national networks … Type: | 16 | 2 | 14 | 371 |
 | Institut de Myologie [Automatic translation follows] Innovate to Heal Located in Paris in the heart of the largest European hospital center, the Pitié-Salpêtrière hospital, the Institute of Myology was created in 1996 under the impetus of an association of patients and parents of patients, the AFM-Téléthon. Its objective: to promote the existence, recognition and development of Myology, the science and medicine of Muscle, as a discipline in its own right. Whether healthy, sick, injured, athletic, aging... the muscle, on which our activity and vital functions depend, has become a true model of innovation for scientific and medical research and a public health issue. … Type: | 16 | 1 | 15 | 139 |
 | institut de Biologie Valrose - iBV Institut de Biologie Valrose - iBV Director: Dr. Stéphane Noselli Affiliations : Université Nice Sophia Antipolis, CNRS (UMR7277), INSERM (U1091), Université Côte dAzur Overall presentation : iBV is an international research institute renowned for its basic research in developmental biology, cell biology, signaling and human pathologies. Quick presentation: 309 collaborators working in 27 research groups; 10 state-of-the-art facilities (animal facilities, PRISM imaging platform (IBiSA), cytometry, histo-pathology, etc..); 400+ Publications in leading international journals; Collaborations with leading private companies. Scientific focus and breakthroughs : The institute addresses broad scientific questions in the field of cell signaling involved in cell and tissue … Type: | 8 | 2 | 3 | 57 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … Type: | 18 | 11 | 10 | 9 |
 | Institut Imagine Institut Imagine, pour guérir les maladies génétiques. Institut Imagine for genetic disease is a French translational research institute which performs state-of-the-art research in order to better understand genetic diseases. The Institute brings together scientists and physicians around the patients in a unique, ultra-modern 19,000 sqm building located within Necker Children’s Hospital, Paris. The teams also benefit from cutting-edge technological platforms and clinical facilities providing methodological advice as well as huge and rationalized cohorts of patients. The objective is to foster translational research and accelerate the development of new therapeutic and diagnostic solutions for the ultimate benefit of the patients and … Type: | 54 | 23 | 38 | 418 |
 | IAST Interdisciplinary research hub in Toulouse aiming to understand fundamental determinants of human behaviour. The Institute for Advanced Study in Toulouse is a unified scientific project whose aim is to study human behavior. We offer an innovative and multidisciplinary approach to science and support researchers from all over the world, trained in the different social sciences to tackle important research questions. Our ambition is to break down artificial disciplinary boundaries to unlock new ideas and address the challenges of the 21st century. Type: | 3 | 1 | 2 | 15 |
 | Hybrigenics Services Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins' functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict … Type: | 7 | 2 | 5 | 33 |
 | SingleCare The Rx savings card more people in America rely on to feel better. At SingleCare we believe that feeling better shouldn’t be painful. Our super-smart system and close relationships with the big pharmacies means we can set lower prices on tens of thousands of drugs. We provide the Rx savings card more people in America rely on to feel better. Healthcare and Pharmaceutical Type: | 3 | 0 | 2 | 174 |
 | Senti Biosciences Outsmarting complex diseases with more intelligent medicines Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell … Type: | 2 | 0 | 2 | 54 |
 | Rheolution We empower Life Sciences and Agri-Food with Soft Matter AnalyticsTM At Rheolution, we design and commercialize IoT-enabled modular lab instruments for modern data-driven science. Our instruments and software empower scientists, engineers, and innovators with a suite of cutting-edge optical and mechanical testing instruments for the Life Sciences and Agri-Food. Our instruments are not only highly modular and scalable but also remarkably intuitive. What sets us apart is our pioneering IoT approach, granting our users and customers unprecedented control over expanding their testing capabilities according to their preferences and needs: - Embrace the potency of IoT-enabled modularity and the adaptability of … Type: | 2 | 1 | 1 | 25 |
 | pymetrics (now Harver) pymetrics is now Harver. Harver is the industry leading hiring solution helping organizations optimize their talent decisions. Rooted in over 35 years of rich data insights backed by I/O psychology and cognitive science, Harver delivers a suite of automated solutions that enables organizations to engage, hire, and develop the right talent in a fast and fundamentally less biased way. Having processed over 100 million candidates, Harver provides trusted, data-driven, and adaptable offerings, including assessments, video interviews, scheduling, and reference checking. Harver has helped more than 1,300 customers, including Booking.com, Peloton, Valvoline, and McDonald’s, take the smart path to the right … Type: | 20 | 7 | 4 | 26 |
 | Prellis Biologics Integrating human biology with machine learning for antibody discovery Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXISTM, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in the same platform. Prellis Biologics, Inc. is a privately held company based in the San Francisco Bay Area, CA. Apply at www.prellisbio.com. Lymph Node Organoids, Immunogenicity Screening, Human Antibody Discovery, and Antibody Discovery Type: | 11 | 3 | 10 | 46 |
 | Pivot Bio Pivot Bio provides farmers and the world with a better nitrogen for improved productivity and sustainability. Pivot Bio is a sustainable agriculture company delivering farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow the food the world needs in the face of increasing volatility. Type: | 11 | 5 | 6 | 394 |
 | PharmaBiome AG Pioneering the development of microbiome-based therapies using proprietary tools for their design and production. PharmaBiome is a privately-held spin-off company of ETH Zurich and a pioneer in the production of live biotherapeutic products to address disturbances of the gut microbiome. It has developed the first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science, PharmaBiome believes that the future of microbiome-based therapeutics lies in developing the biotechnology needed to produce a solution compatible with the safety, efficiency, and trial requirements of any human medicine. This … Type: | 1 | 0 | 0 | 11 |
 | Activatec Ltd Technology development, R&D, Biobased ingredients Activatec develops technologies to produce biobased ingredients from renewable sources. We are specialised in the evaluation, scale-up and commercialisation of processes to produce biotechnological and plant-based ingredients and materials from currently unused and low-value organic sources. Activatec is a B2B Partner that provides support to the industrial biotechnology sector in the form of research services on a contract basis. We are currently working within a number of international partner projects to design, develop and scale-up novel technologies for the production of emerging and high-value bio-based products. biotechnology, research and development, biotech, biobased products, bioproducts, bioingredients, … Type: | 2 | 0 | 1 | 1 |
 | Enifer The brewers of PEKILO, the original mycoprotein. Sustainable protein is ready for scale! We are upcycling food industry by-products into planet-friendly protein, and pioneering a new approach to food systems—one that supports healthy, delicious diets for everyone while minimizing environmental impact. Enifer, a spin-off company from VTT Technical Research Centre of Finland, was founded by five scientists in 2020 to develop and commercialize the proprietary PEKILO® technology further. A process originally developed and used by the Finnish forest industry at a commercial scale, the PEKILO® technology enables the biotechnological conversion of dilute side streams into a high-protein and fiber ingredient, … Type: | 3 | 2 | 1 | 29 |
 | Lindus Health We are an anti-CRO running end-to-end clinical trials for life science pioneers. Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers. We do this thanks to a commercial model that aligns incentives (fixed-price quotes per study, with milestone-based payments), marrying a world-class clinical operations team with our unique software platform, and access to 30 million Electronic Health Records. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. We have helped over 100 sponsors run entire clinical studies across the US, UK, and Europe … Type: | 8 | 0 | 8 | 99 |
 | Hilltop Leaf Ltd Plant based medicine Hilltop Leaf Ltd is a U.K. plant based Medicine Company | 1 | 1 | 0 | 11 |
 | Mitra bio Unlocking the secrets of skin aging with epigenetics Next Generation Skin Health Type: | 3 | 2 | 1 | 8 |
 | OPUS Life Sciences, LLC OPUS Life Sciences, LLC is dedicated to addressing the needs of healthcare providers and patients through innovative eye care supplements, eyelid wipes, eye vitamins and more. We’re constantly discovering and developing new medicines, devices and supplements for eye health to improve peoples’ quality of life. Type: | 2 | 1 | 0 | 10 |
 | Orano Med Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information … Type: | 10 | 2 | 10 | 152 |
 | OpenCell HIRING! Biotech makes the world a better place to live, so we’re making labs that are a better place to work. With so much potential for biotech to make the world a better place to live, we knew we needed to make the lab a better place to work. We’re a team of scientists and designers who have meticulously studied the in-lab experience, getting a detailed understanding of workflows and identifying common pain points that routinely cost scientists time and money. Our BioHotel labs are designed with biotech startups in mind: - Short term, flexible leases - Central London locations … | 5 | 3 | 2 | 8 |
 | Oncomfort Digital SedationTM is a drug-free therapy reducing patients' anxiety and pain during medical treatments and procedures. Oncomfort Digital SedationTM is a non-pharmacological therapy for relieving patients’ pain and anxiety before, during and after medical procedures. This digital therapy combines clinical hypnosis and integrative therapeutic techniques through Virtual Reality. Virtual Reality, Medical, Anxiety Management, Oncology, Pain Management, Radiology, eHealth, Digital Sedation, Sedation, and Clinical Hypnosis Type: | 12 | 10 | 1 | 5 |
 | Nuproxa Group of Companies Smart nutrition, naturally! High quality solutions for the animal nutrition and health industry. Nuproxa is a Swiss company founded in 2007, supplying high-quality solutions to the Animal Nutrition and Health Industry. Our solutions are 100% based on nature! With technology created by nature, unquestionably safe. Effective, with results demonstrated by scientific experiments and field tests in real conditions. Applicable to efficiently solve real problems faced by the ANH industry. Vision Nuproxa aims to contribute to a world where the well-being and nutrition of animals is provided by nature-based ingredients. Our commitment is to be the preferred supplier of natural solutions … Type: | 2 | 2 | 0 | 60 |
 | Migraine Again Digital content company publishing daily news, tips and stories on ending migraine pain to help 500 million patients worldwide. We're leveraging the power of digital media (web, social, video) to radically improve lives of migraine sufferers - and others with chronic health problems for which there is no cure. Our mission is to help patients access unbiased, world-class insights and solutions to suffer less, live and work more – until there’s a cure. We empower patients with community and information they're not getting locally - effectively democratizing access to the world's top medical providers and cutting edge research. Better quality … Type: | 1 | 1 | 0 | 12 |
 | JooMo Ltd. Get your DREAM SKIN: Young, Clear & Radiant Skin using the power of the Skin Microbiome! We are the World's First 100% Truly Natural Face Wash. Our products are all free from preservatives, chemicals, and 'naturally derived' ingredients. Our Company is based on years of research and scientific studies we have conducted with ground breaking results. Our formulations get the skin to HEAL itself by increasing the biodiversity of your skin's microbiome! We are a small company created in 2010 by a small British family, who simply wanted better products to heal their skin problems. We care about our customers … Type: | 0 | 0 | 0 | 6 |
 | IT Cosmetics Discover IT. Love IT. Believe IT. Innovative Technology is IT. Developed with leading plastic surgeons, IT Cosmetics creates clinically-proven, innovative problem-solving makeup and skin care products that harness cutting edge, anti-aging technologies and high-performance, skin-loving ingredients to provide you with serious beauty solutions that help you look and feel your most beautiful! Our mission is to empower you through confidence in your skin, your makeup and your own beauty. IT’s your beauty, but better! Makeup, Cosmetics, Beauty, and Technology | 5 | 3 | 1 | 567 |
 | Marginum Marginum is a university-based medical technology startup developing fluorescence-based tissue detection systems. The Company’s data-driven solutions enable safe and efficient monitoring of tumor tissues during cancer surgery without compromising pre-existent surgical workflows. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’s multidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions’ seamless clinical compatibility. Type: | 1 | 0 | 1 | 10 |
 | HAYA Therapeutics Inspired to Transform, The Genome Informs - RNA-Guided Therapeutics to Target Disease Causing Cell-States HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing … Type: | 3 | 2 | 0 | 51 |
 | MucoLife Therapeutics We develop novel mucolytic drugs to transform the treatment landscape of COPD and other lung diseases. We develop novel mucolytic drugs to transform the treatment landscape of COPD and other lung diseases. COPD and Mucus Type: | 0 | 0 | 0 | 2 |
 | ILC Therapeutics ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy. ILC Therapeutic’s platform approach has produced two first-in-class lead candidates, AlfacyteTM and DermacyteTM focused on antiviral and dermatological indications respectively, which are progressing towards the clinic. Type: | 0 | 0 | 0 | 7 |
 | Epitopea Exploiting a new class of tumour specific antigens for cancer therapy A newly established NewCo developing therapeutics targeting a novel class of tumour-specific antigen. TCR-T cells, Immuno-oncology, Vaccines, Bi-specifics, Splicing, Epigenetics, Oncology, T cell biology, and Antigen presentation Type: | 3 | 0 | 3 | 21 |
 | Mestag Therapeutics New therapies for cancer and inflammatory disease targeting fibroblast-immune interactions Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are advancing a pipeline of first-in-class tailored antibody programs and targets for new treatments. Backed by committed leading global investors, world-class founders and a highly experienced leadership team, Mestag offers an exciting, diverse and balanced place to work, with competitive benefits, generous vacation time and the room to grow and develop your career. biotechnology, fibroblasts, oncology, immuno oncology, inflammatory disease, and datascience Type: | 0 | 0 | 0 | 54 |
 | XO Life Enabling better Patient Education, Treatment Support and Real World Evidence from Patient Insights 🌎 XO Life stands for ✅ a state-of-the-art platform solution for long-term Patient Insights from the real world ✅ real time information exchange between patients and pharma ✅ a all-in-one platform to be used across all treatments and indications We are a young and dynamic eHealth company setting a new standard patient data collection through scientifically based questionnaires across all treatments and medications. XO Life helps the pharmaceutical industry to better understand its patients. Our goal is to make digital treatment monitoring and patient feedback the gold … Type: | 1 | 0 | 1 | 37 |
 | CardiaTec Biosciences Decoding cardiovascular disease biology for novel therapeutic discovery CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. We leverage large and high-dimensional human omics data to better navigate complex disease biology to discover novel and differentiated therapeutics. Type: | 5 | 2 | 2 | 10 |
 | PANTERA A Better Fight for Life PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general. | 4 | 2 | 4 | 22 |
 | M-Based M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental conservation and ethical principles throughout our production process. Our primary goal is to lead sustainable textiles with our 'Mushroom-Based Vegan Leather,' derived from mycelium! Don't miss out on our efforts for a greener future! Stay connected for updates and progress. 🌱 Type: | 2 | 2 | 0 | 6 |
 | PILA PHARMA We are a #TRPV1 focused company developing oral treatments for Type-2 #Diabetes & #Erythromelalgia PILA PHARMA is a publicly held clinical stage pharmaceutical company based in Malmö, Sweden. PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes. | 2 | 1 | 0 | 9 |
 | PL BioScience GmbH Changing cell culture with animal-free cell growth promoters We at PL BioScience are experts in cell culture supplements derived from human Platelets. Our mission is to enhance the advances in cellular research and therapy with one forward-looking Technology: ELAREMTM. The ELAREMTM Platform unites tailored cell culture supplements based on Human Platelet Lysate. The human origin combined with a rich growth factor content not only supports cell growth, but also enables various applications: The products cover all needs of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from lab to patients … Type: | 0 | 0 | 0 | 25 |
 | ILYA Pharma Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients ATMP, Gene Therapy, Biologics, Drug development, Clinical trials, GMP, Growth, H2020, Uppsala, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, Cutting edge, and IBD Type: | 7 | 0 | 5 | 17 |
 | HEXO Corp HEXO Corp est une entreprise primée de biens de grande consommation qui conçoit et distribue des produits de cannabis destinés au marché mondial, produits récompensés par plusieurs prix. Dans le cadre de sa stratégie commerciale en étoile, HEXO Corp s’associe à des entreprises du Fortune 500, leur apportant la valeur de sa marque, sa technologie d’isolement des cannabinoïdes, son infrastructure sous licence et son expertise en réglementation, tirant parti à son tour de leurs réseaux et capacités de distribution. L’une des plus importantes entreprises autorisées de production de cannabis au Canada, HEXO déploie ses activités sur 2 000 000 pi2d’installations … Type: | 0 | 0 | 0 | 248 |
Startup